Alzheimer's Disease, Other Dementias, and LDN

Stuart says “I am currently a candidate for Ph.D in Psychology/Gerontology via University of California-San Francisco, USA.

I have now completed about 75% of my doctoral thesis, loosely titled Stress and its Relation to and Effect Upon Alzheimer's Disease and Other Dementias.  It is my postulation that unnatural stress applied to the human body (in particular the brain and central nervous system) is largely complicit in the creation of the plaque of amyloid-beta and tau that fouls the synapses of cranial neurons and prevents the free flow of information between parts of the brain and between the brain and the rest of the body.  I believe that this is a major reason that human populations within the United States that are traditionally thought of as inordinately stressed via factors such as poverty, disenfranchisement, under-education and inactivity appear to have a high correlation to the acquisition of (particularly) Alzheimer's Disease.

It has been suggested to me that many of the aspects that figure in the creation of Alzheimer's are also present in the onset of multiple sclerosis.  A friend and colleague, Dr. Don Schwartz, Ph.D, introduced me to the research around low doses of the opioid inhibitor Naltrexone, which, as prescribed, has been known to successfully blunt the symptoms of MS and the possibility that LDN might be even a little effective upon incidences of Alzheimer's and/or other dementias, given the apparent similarities in the construction of MS and these dementias.

I would like to learn from some of those with great experience in application and research of this remarkable drug...the knowledge I accumulate may be very important to the completion of my thesis”. 

To contact Stuart, please our Contact Us form, which we will forward to him.

The LDN Research Trust thank you for your support and we wish Stuart every success with his thesis.